NYSE:RFL - New York Stock Exchange, Inc. - US75062E1064 - Common Stock - Currency: USD
RAFAEL HOLDINGS INC-CLASS B
NYSE:RFL (2/11/2025, 8:04:00 PM)
2.11
+0.03 (+1.44%)
The current stock price of RFL is 2.11 USD. In the past month the price increased by 11.64%. In the past year, price increased by 12.83%.
Upon completion of our proposed merger with Cyclo Therapeutics the Company intends to focus its efforts on Cyclo’s lead clinical program Trappsol® Cyclo™
Upon completion of our proposed merger with Cyclo Therapeutics the Company intends to focus its efforts on Cyclo’s lead clinical program Trappsol® Cyclo™...
Our proposed merger with Cyclo Therapeutics advances our strategy to invest in, develop and commercialize clinical stage assets which address areas of high unmet medical need
Our proposed merger with Cyclo Therapeutics advances our strategy to invest in, develop and commercialize clinical stage assets which address areas of high...
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LB | LANDBRIDGE CO LLC-A | N/A | 5.62B | ||
VTMX | CORP INMOBILIARIA VESTA-ADR | 4.86 | 2.28B | ||
KW | KENNEDY-WILSON HOLDINGS INC | N/A | 1.23B | ||
IRS | IRSA -SP ADR | N/A | 935.05M | ||
MRNO | MURANO GLOBAL INVESTMENTS PL | N/A | 856.58M | ||
FRPH | FRP HOLDINGS INC | 57.31 | 599.83M | ||
SEG | SEAPORT ENTERTAINMENT GROUP | N/A | 323.34M | ||
LPA | LOGISTIC PROPERTIES OF THE A | N/A | 301.46M | ||
OZ | BELPOINTE PREP LLC | N/A | 239.96M | ||
TCI | TRANSCONTINENTAL REALTY INV | 73.11 | 233.71M | ||
ARL | AMERICAN REALTY INVESTORS IN | N/A | 217.86M | ||
SRG | SERITAGE GROWTH PROP- A | N/A | 199.20M |
Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. The company is headquartered in Newark, New Jersey and currently employs 28 full-time employees. The company went IPO on 2018-03-12. Its segments include Healthcare, Infusion Technology and Real Estate. The Healthcare segment holds interest in LipoMedix Pharmaceuticals Ltd. (LipoMedix), Barer Institute Inc. (Barer), Cornerstone Pharmaceuticals, Inc. (Cornerstone) and Rafael Medical Devices, LLC. The Real Estate segment consists of the Company’s real estate holdings, which is comprised of a portion of a commercial building in Israel. The Infusion Technology segment holds interest in Day Three Labs, Inc. LipoMedix is a clinical-stage pharmaceutical company. Rafael Medical Devices, LLC, an orthopedic-focused medical device company. Cornerstone Pharmaceuticals, Inc. is a cancer metabolism-based therapeutics company. Cyclo Therapeutics Inc. develops Trappsol Cyclo, which is being evaluated in clinical trials for the treatment of Niemann-Pick Disease Type C1 (NPC).
RAFAEL HOLDINGS INC-CLASS B
520 Broad Street
Newark NEW JERSEY 07102 US
CEO: Ameet Mallik
Employees: 13
Company Website: https://rafaelholdings.com
Investor Relations: https://rafaelholdings.irpass.com/
Phone: 12126581450
The current stock price of RFL is 2.11 USD.
The exchange symbol of RAFAEL HOLDINGS INC-CLASS B is RFL and it is listed on the New York Stock Exchange, Inc. exchange.
RFL stock is listed on the New York Stock Exchange, Inc. exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for RFL, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of RFL.
RFL does not pay a dividend.
RFL will report earnings on 2025-03-11.
RFL does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.45).
The outstanding short interest for RFL is 0.54% of its float.
ChartMill assigns a technical rating of 8 / 10 to RFL. When comparing the yearly performance of all stocks, RFL is one of the better performing stocks in the market, outperforming 77.74% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to RFL. RFL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months RFL reported a non-GAAP Earnings per Share(EPS) of -1.45. The EPS increased by -1716.77% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -35.54% | ||
ROE | -41.87% | ||
Debt/Equity | 0.03 |